Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Abexinostat |
| Trade Name | |
| Synonyms | PCI-24781|S-78454|CRA-024781 |
| Drug Descriptions |
Abexinostat (PCI-24781) is an HDAC inhibitor, which induces tumor cell apoptosis and decreases tumor cell growth (PMID: 16731764, PMID: 25520806). |
| DrugClasses | HDAC Inhibitor 45 |
| CAS Registry Number | 783355-60-2 |
| NCIT ID | C68920 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abexinostat | Abexinostat | 0 | 1 |
| Abexinostat + Aldoxorubicin | Abexinostat Aldoxorubicin | 0 | 0 |
| Abexinostat + Doxorubicin | Abexinostat Doxorubicin | 0 | 0 |
| Abexinostat + Fulvestrant + Palbociclib | Abexinostat Fulvestrant Palbociclib | 0 | 1 |
| Abexinostat + Ibrutinib | Abexinostat Ibrutinib | 0 | 1 |
| Abexinostat + Pazopanib | Abexinostat Pazopanib | 0 | 1 |
| Abexinostat + Pembrolizumab | Abexinostat Pembrolizumab | 0 | 1 |
| Abexinostat + Temozolomide | Abexinostat Temozolomide | 0 | 1 |